Reality vs. Fantasy

This morning Abbott reported fourth quarter and full year results which for Libre came in as expected. For the full year diabetes care sales surpassed the $3 Billion level coming in at almost $3.3 Billion. With results like that, with a market that continues to grow, with system adoption increasing and new applications being found it’s easy to understand why everyone is going gaga over these rumors that Apple and Samsung are about to enter the market.

Let’s make something very clear from the start Apple and Samsung MAY enter this market one day but that . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

© 2005 - 2021 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.